ALKBH5 regulates ACSL4 to sensitize erastin-induced ferroptosis via YTHDF2-dependent m6A modification in hypoxic pulmonary hypertension

Jul 27, 2025Free radical biology & medicine

ALKBH5 controls ACSL4 to increase sensitivity to erastin-triggered cell death in low-oxygen lung hypertension through YTHDF2-related RNA modification

AI simplified

Circadian Biology on OpenScience ↗PubMed ↗DOI ↗

Abstract

Erastin application in hypoxic pulmonary artery smooth muscle cells increased malondialdehyde levels and reactive oxygen species.

Hypoxic conditions made pulmonary artery smooth muscle cells (PASMCs) more susceptible to erastin-induced ferroptosis.
Ferrostatin-1 inhibited the increase of malondialdehyde and reactive oxygen species caused by erastin.
ACSL4 expression levels were notably increased in PASMCs and hypoxic pulmonary hypertension (HPH) rat lung tissues.
ACSL4 was identified to have a dual role, promoting PASMC proliferation while also contributing to lipid peroxidation and sensitivity to ferroptosis.
Increased levels of AlkB homolog 5 (ALKBH5) in hypoxic PASMCs correlated with reduced mA levels, downregulating ACSL4 and lipid peroxidation.
Administering erastin to HPH rats led to increased ACSL4 expression, enhanced lipid peroxidation, and alleviated pulmonary hypertension.

AI simplified

Hypoxic pulmonary hypertension (HPH) is a common complication derived from chronic hypoxic lung diseases and is characterized by excessive proliferation of pulmonary artery smooth muscle cells (PASMCs) and obvious pulmonary vascular remodeling (PVR). Despite recent advances, the clinical outcome is still unsatisfactory. Ferroptosis, a newly identified form of programmed cell death, has been reported to participate in cardiovascular disease progression; however, its role in HPH remains undefined. Here, we demonstrate the feasibility of ferroptosis induction and propose an innovative regulatory mechanism by which mA methylation modulates ferroptosis in HPH. We observed that PASMCs exposed to hypoxia were susceptible to erastin-induced ferroptosis. Erastin application increased malondialdehyde (MDA) and reactive oxygen species (ROS) levels, and this effect was abrogated by ferrostatin-1. Moreover, hypoxia notably upregulated acyl-CoA synthetase long-chain family member 4 (ACSL4) expression levels, as well as 5-HETE and MDA levels in both PASMCs and HPH rats. We are the first to identify ACSL4 as having a dual role in HPH, which not only promotes hypoxic PASMC proliferation, but also accounts for lipid peroxidation and sensitivity to erastin-induced ferroptosis. Additionally, mA levels were reduced in hypoxic PASMCs and HPH rat lung tissues, accompanied by a significant increase in AlkB homolog 5 (ALKBH5). Loss of ALKBH5 downregulated ACSL4 mRNA and protein levels, depressed lipid peroxidation and rendered hypoxic PASMCs resistant to erastin-induced ferroptosis. Mechanistically, ALKBH5 permitted ACSL4 mRNA to sustain mA demethylation to evade YTH N6-methyladenosine RNA binding protein 2 (YTHDF2)-mediated mRNA decay through binding to mA-modified sites in the 3'UTR of ACSL4 mRNA. Furthermore, the administration of erastin to HPH rats increased ACSL4 expression, augmented lipid peroxidation, effectively reversed PVR and alleviated pulmonary hypertension. Collectively, our findings suggest that erastin-induced ferroptosis is a promising therapeutic approach for HPH and that intervention with ACSL4 or mA modulators may have a synergistic effect. 6 6 6 6 6

Full Text

Full text is available at the source.

View full text (XML) ↗View full text ↗

ALKBH5 regulates ACSL4 to sensitize erastin-induced ferroptosis via YTHDF2-dependent m6A modification in hypoxic pulmonary hypertension

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the circadian biology brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the circadian biology brief